Natural killer cell cytokine receptors

Natural killer (NK) cell cytokine receptors are a collection of cell-surface signaling proteins that orchestrate the activation, expansion, and cytotoxic potential of NK cells. This group primarily includes receptors for Interleukin-2 (IL-2), IL-12, IL-15, IL-18, and IL-21, which are crucial for the innate immune system's surveillance and elimination of tumor cells and intracellular pathogens (Source: PubMed, PMID: 30612864). These receptors typically function as multi-subunit complexes that, upon ligand binding, activate intracellular signaling cascades such as the JAK-STAT, PI3K/Akt, and MAPK pathways (Source: UniProt). In therapeutic applications, these receptors are targeted by cytokine mimetics and superagonists to enhance anti-tumor immunity, with IL-15-based therapies like Nogapendekin alfa inbakicept showing particular promise due to their relative selectivity for NK cells and CD8+ T cells over immunosuppressive T-regulatory cells (Source: FDA, PubMed, PMID: 35115370). However, systemic administration of these agonists can lead to severe side effects, including vascular leak syndrome and cytokine release syndrome, which remain significant hurdles in clinical development (Source: StatPearls). Ongoing research focuses on engineering biased cytokines or targeted delivery systems to maximize NK cell activation while minimizing systemic toxicity.

Other names

NK cell cytokine receptorsInterleukin receptors on natural killer cellsCytokine receptors (NK cells)

Agonism of cytokine receptors (e.g., IL-2R, IL-15R) to trigger JAK-STAT signaling, leading to NK cell proliferation, survival, and enhanced cytotoxic effector functions against target cells.